Skin permeation experiments have been broadly done since 1970s to 1980s as an evaluation method for transdermal drug delivery systems. In topically applied drug and cosmetic formulations, skin concentration of chemical compounds is more important than their skin permeations, because primary target site of the chemical compounds is skin surface or skin tissues. Furthermore, the direct pharmacological reaction of a metabolically stable drug that binds with specific receptors of known expression levels in an organ can be determined by Hill’s equation. Nevertheless, little investigation was carried out on the test method of skin concentration after topically application of chemical compounds. Recently we investigated an estimating method of skin concentration of the chemical compounds from their skin permeation profiles. In the study, we took care of “3Rs” issues for animal experiments. We have proposed an equation which was capable to estimate animal skin concentration from permeation profile through the artificial membrane (silicone membrane) and animal skin. This new approach may allow the skin concentration of a drug to be predicted using Fick’s second law of diffusion. The silicone membrane was found to be useful as an alternative membrane to animal skin for predicting skin concentration of chemical compounds, because an extremely excellent extrapolation to animal skin concentration was attained by calculation using the silicone membrane permeation data. In this chapter, we aimed to establish an accurate and convenient method for predicting the concentration profiles of drugs in the skin based on the skin permeation parameters of topically active drugs derived from steady-state skin permeation experiments.
References
[1]
Knepp, V.M.; Hadgraft, J.; Guy, R.H. Transdermal drug delivery: Problems and possibilities. Crit. Rev. Ther. Drug Carr. Syst. 1987, 4, 13–37.
[2]
Kano, S.; Sugibayashi, K. Kinetic analysis on the skin disposition of cytotoxicity as an index of skin irritation produced by cetylpyridinium chloride: Comparison of in vitro data using a three-dimensional cultured human skin model with in vivo results in hairless mice. Pharm. Res. 2006, 23, 329–335, doi:10.1007/s11095-006-9141-z.
[3]
Huffman, D.H.; Crow, J.W.; Pentik？inen, P.; Azarnoff, D.L. Association between clinical cardiac status, laboratory parameters, and digoxin usage. Am. Heart J. 1976, 91, 28–34, doi:10.1016/S0002-8703(76)80431-0.
[4]
Sheiner, L.B.; Rosenberg, B.; Marathe, W. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. J. Pharmacokin. Biopharm. 1977, 5, 445–479, doi:10.1007/BF01061728.
[5]
Vozeh, S.; Hillman, R.; Wandell, M.; Ludden, T.; Sheiner, L. Computer-assisted drug assay interpretation based on Bayesian estimation of individual pharmacokinetics: Application to lidocaine. Ther. Drug Monit. 1985, 7, 66–73, doi:10.1097/00007691-198503000-00011.
[6]
Sato, K.; Oda, T.; Sugibayashi, K.; Morimoto, Y. Estimation of blood concentration of drugs after topical application from in vitro skin permeation data. I. Prediction by convolution and confirmation by deconvolution. Chem. Pharm. Bull. 1988, 36, 2232–2238, doi:10.1248/cpb.36.2232.
[7]
Sato, K.; Oda, T.; Sugibayashi, K.; Morimoto, Y. Estimation of blood concentration of drugs after topical application from in vitro skin permeation data. II. Approach by using diffusion model and compartment model. Chem. Pharm. Bull. 1988, 36, 2624–2632, doi:10.1248/cpb.36.2624.
[8]
Hatanaka, T.; Katayama, K.; Koizumi, T.; Sugibayashi, K.; Morimoto, Y. In vitro–in vivo correlation of percutaneous absorption: Isosorbide dinitrate and morphine hydrochloride. Biol. Pharm. Bull. 1994, 17, 826–830, doi:10.1248/bpb.17.826.
[9]
Kiistala, U. Suction blister device for separation of viable epidermis from dermis. J. Invest. Dermatol. 1968, 50, 129–137.
[10]
Surber, C.; Wilhelm, K.P.; Bermann, D.; Maibach, H.I. In vivo skin penetration of acitretin in volunteers using three sampling techniques. Pharm. Res. 1993, 10, 1291–1294, doi:10.1023/A:1018961511730.
[11]
Surber, C.; Wilhelm, K.P.; Hori, M.; Maibach, H.I.; Guy, R.H. Optimization of topical therapy: Partitioning of drugs into stratum corneum. Pharm. Res. 1990, 7, 1320–1324, doi:10.1023/A:1015958526423.
[12]
Schaefer, H.; Stüttgen, G.; Zesch, A.; Schalla, W.; Gazith, J. Quantitative determination of percutaneous absorption of radiolabeled drugs in vitro and in vivo by human skin. Curr. Probl. Dermatol. 1978, 7, 80–94.
[13]
Pershing, L.K.; Silver, B.S.; Krueger, G.G.; Shah, V.P.; Skelley, J.P. Feasibility of measuring the bioavailability of topical betamethasone dipropionate in commercial formulations using drug content in skin and a skin blanching bioassay. Pharm. Res. 1992, 9, 45–51, doi:10.1023/A:1018975626210.
[14]
Rougier, A.; Dupuis, D.; Lotte, C.; Roguet, R.; Schaefer, H. In vivo correlation between stratum corneum reservoir function and percutaneous absorption. J. Invest. Dermatol. 1983, 81, 275–278.
[15]
N’Dri-Stempfer, B.; Navidi, W.C.; Guy, R.H.; Bunge, A.L. Improved bioequivalence assessment of topical dermatological drug products using dermatopharmacokinetics. Pharm. Res. 2009, 26, 316–328, doi:10.1007/s11095-008-9742-9.
[16]
Anissimov, Y.G.; Roberts, M.S. Modelling dermal drug distribution after topical application in human. Pharm Res. 2011, 28, 2119–2129, doi:10.1007/s11095-011-0437-2.
[17]
Lodén, M.; Ungerth, L.; Serup, J. Changes in European legislation make it timely to introduce a transparent market surveillance system for cosmetics. Acta Derm. Venereol. 2007, 87, 485–492, doi:10.2340/00015555-0311.
[18]
Toyoda, H. Regulation of the animal experiments and testing in EU. Envir. Mutagen. Res. 2005, 27, 125–128, doi:10.3123/jems.27.125.
[19]
Kolar, R. Animal experimentation. Sci. Eng. Ethics 2006, 12, 111–122.
[20]
Spielmann, H. Animal use in the safety evaluation of chemicals: Harmonization and emerging needs. ILAR J. 2002, 43, S11–S17.
[21]
Leveque, N.; Raghavan, S.L.; Lane, M.E.; Hadgraft, J. Use of a molecular form technique for the penetration of supersaturated solutions of salicylic acid across silicone membranes and human skin in vitro. Int. J. Pharm. 2006, 318, 49–54, doi:10.1016/j.ijpharm.2006.03.015.
[22]
Ottaviani, G.; Martel, S.; Carrupt, P. Parallel artificial membrane permeability assay: A new membrane for the fast prediction of passive human skin permeability. J. Med. Chem. 2006, 49, 3948–3954, doi:10.1021/jm060230+.
[23]
Hatanaka, T.; Inuma, M.; Sugibayashi, K.; Morimoto, Y. Prediction of skin permeability of drugs. I. Comparison with artificial membrane. Chem. Pharm. Bull. 1990, 38, 3452–3459, doi:10.1248/cpb.38.3452.
[24]
Geinoz, S.; Rey, S.; Boss, G.; Bunge, A.L.; Guy, R.H.; Carrupt, P.A.; Reist, M.; Testa, B. Quantitative structure: Permeation relationships for solute transport across silicone membranes. Pharm. Res. 2002, 19, 1622–1629, doi:10.1023/A:1020745026766.
[25]
Herkenne, C.; Naik, A.; Kalia, Y.N.; Hadgraft, J.; Guy, R.H. Ibuprofen transport into and through skin from topical formulations: In vitro–in vivo comparison. J. Investig. Dermatol. 2007, 127, 135–142, doi:10.1038/sj.jid.5700491.
[26]
Hada, N.; Hasegawa, T.; Takahashi, H.; Ishibashi, T.; Sugibayashi, K. Cultured skin loaded with tetracycline HCl and chloramphenicol as dermal delivery system: Mathematical evaluation of the cultured skin containing antibiotics. J. Control. Release 2005, 108, 341–350, doi:10.1016/j.jconrel.2005.08.020.
[27]
Scheuplein, R.J.; Blank, I.H. Mechanism of percutaneous absorption. IV. Penetration of nonelectrolytes (alcohols) from aqueous solutions and from pure liquids. J. Investig. Dermatol. 1973, 60, 286–296.
[28]
Hasegawa, T.; Kim, S.; Tsuchida, M.; Isshiki, Y.; Kondo, S.; Sugibayashi, K. Decrease in skin permeation and antibacterial effect of parabens by a polymeric additive, poly(2-methacryloyloxyethyl phosphorylcholine-cobutylmetacrylate). Chem. Pharm. Bull. 2005, 53, 271–276, doi:10.1248/cpb.53.271.
[29]
Scheuplein, R.J. Mechanism of percutaneous absorption: Transient diffusion and the relative importance of various routes of skin penetration. J. Investig. Dermatol. 1967, 48, 79–88.
[30]
Watanabe, T.; Hasegawa, T.; Takahashi, H.; Ishibashi, T.; Sugibayashi, K. Utility of three-dimensional cultured human skin model as a tool to evaluate skin permeation drugs. Altern. Anim. Test. Exp. 2001, 8, 1–14.
[31]
Ghanem, A.H.; Mahmoud, H.; Higuchi, W.I.; Liu, P. The effects of ethanol on the transport of lipophilic and polar permeants across hairless mouse skin: Methods/validation of a novel approach. Int. J. Pharm. 1992, 78, 137–156, doi:10.1016/0378-5173(92)90365-9.
